Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 9/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.35 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2339806 | 0.97 | LMNA (0.41) | OPRM1LMNADNM1HTTTSHR | |
| SCHEMBL8327147 | 0.97 | LMNA (0.41) | OPRM1LMNADNM1HTTTSHR | |
| SCHEMBL15310044 | 0.97 | LMNA (0.41) | OPRM1LMNADNM1HTTTSHR | |
| Bromide SCHEMBL21253076 | 0.95 | DNM1 (0.42) | OPRM1LMNADNM1HTTTSHR | |
| Hydrochloric Acid SCHEMBL114418 | 0.95 | DNM1 (0.42) | OPRM1LMNADNM1HTTTSHR | |
| Hydrochloric Acid SCHEMBL9465437 | 0.95 | DNM1 (0.42) | OPRM1LMNADNM1HTTTSHR | |
| Bromide SCHEMBL8402695 | 0.95 | DNM1 (0.42) | OPRM1LMNADNM1HTTTSHR | |
| Bromide SCHEMBL21247653 | 0.95 | DNM1 (0.42) | OPRM1LMNADNM1HTTTSHR | |
| Bromide SCHEMBL21253115 | 0.95 | DNM1 (0.42) | OPRM1LMNADNM1HTTTSHR | |
| Hydrochloric Acid SCHEMBL21253135 | 0.95 | DNM1 (0.42) | OPRM1LMNADNM1HTTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1791386-A | Small-particle pharmaceutical formulations of antiseizure and antidementia agents and immunosuppressive agents | BAXTER INT (US) | 2006-06-21 | — | — | CN | disclosed |